Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Tax

Income Tax
12 Months Ended
Dec. 31, 2019
Major components of tax expense (income) [abstract]  



The Company and its subsidiary are taxed under Israel tax laws:


A. Tax rates


The corporate tax rates applicable to 2019, 2018 and 2017 are 23%, 23% and 24%, respectively.


B. Tax assessments


The Company and its subsidiary have tax assessments that are considered to be final through tax year 2014.


C. Losses for tax purposes carried forward to future years


As of December 31, 2019, CollPlant Biotechnologies Ltd. and CollPlant Ltd had approximately $4,506, and $50,309, respectively, of net carry forward tax losses which are available to reduce future taxable income with no limited period of use.


D. Deferred income taxes


    As of December 31,  
    2019     2018  
In respect of:            
Net operating loss carry forward   $ 12,607     $ 10,170  
Research and development expenses     801       753  
Less – valuation allowance     (13,408 )     (10,923 )
Net deferred tax assets   $ -     $ -  


Realization of deferred tax assets is contingent upon sufficient future taxable income during the period that deductible temporary differences and carry forward losses are expected to be available to reduce taxable income. As the achievement of required future taxable income is not likely, the Company recorded a full valuation allowance.


E. Reconciliation of theoretical tax expenses to actual expenses


The primary difference between the statutory tax rate of the Company and the effective rate results virtually from the changes in valuation allowance in respect of carry forward tax losses and research and development expenses due to the uncertainty of the realization of such tax benefits.


F. Uncertain tax positions


As of December 31, 2019 and 2018, the Company does not have a provision for uncertain tax positions.


G. Roll forward of valuation allowance:


Balance at January 1, 2017   $ 9,051  
Additions     2,104  
Balance at December 31, 2017   $ 11,155  
Additions     (232 )
Balance at December 31, 2018   $ 10,923  
Additions     2,485  
Balance at December 31, 2019   $ 13,408